Fig. 3: Overall survival (OS) of patients from both cohorts divided by age intervals.
A OS of all patients. B–D OS of patients assigned to the 2022 ELN genetic-risk groups: B favorable, C intermediate and D adverse.
Fig. 3: Overall survival (OS) of patients from both cohorts divided by age intervals. | Leukemia
